Katarzyna Borg

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Giovanni Cazzaniga, Vincent H. J. van der Velden, J M Cayuela et al. · Leukemia · 2019 · 75 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Novel mutation of <i>IL1RAPL1</i> gene in a nonspecific X‐linked mental retardation (MRX) family

Magdalena Nawara, Jakub Klapecki, Katarzyna Borg et al. · American Journal of Medical Genetics Part A · 2008 · 46 citations

Molecular analysis of a constitutional complex genome rearrangement with 11 breakpoints involving chromosomes 3, 11, 12, and 21 and a ∼0.5-Mb submicroscopic deletion in a patient with mild mental retardation

Katarzyna Borg, Paweł Stankiewicz, Ewa Bocian et al. · Human Genetics · 2005 · 33 citations

Cytogenetics, Genetics, Molecular Biology +16

Application of metaphase HR‐CGH and targeted chromosomal microarray analyses to genomic characterization of 116 patients with mental retardation and dysmorphic features

Beata Nowakowska, Paweł Stankiewicz, Ewa Obersztyn et al. · American Journal of Medical Genetics Part A · 2008 · 23 citations

Comparison of promoter DNA methylation and expression levels of genes encoding CCAAT/enhancer binding proteins in AML patients

Ewa Musialik, Mateusz Bujko, Paulina Kober et al. · Leukemia Research · 2014 · 20 citations

Chromatin, Transcriptional Regulation, Expression Levels +13